Bionov is to introduce Cellulight S, which it describes as a 100% natural active nutricosmetic ingredient for instant drink application and which the company says is the only ingredient with clinically demonstrated efficacy against cellulite.
It has a newly-developed coating to assure total dispersion in cold beverages. Stable in water and acid conditions, this grade S coating is also tasteless and colourless.
Cellulight S is a natural melon juice concentrate rich in superoxide dismutase (SOD), and was recognised as the Beauty Innovation of the year 2012 by the NuW Excellence Awards jury, at the Health Ingredients Europe Show in Frankfurt.
A double-blind, randomised placebo controlled clinical study on 41 healthy women with cellulite on thighs and/or stomach has demonstrated, according to the company, that Cellulight administered orally (40mg/day) reduces cellulite up to 9.5% (compared to placebo) after only 28 days of supplementation. This decrease reaches 11.3% after 56 days of supplementation. Results are said to have shown that the more cellulite is pronounced, the more Cellulight is efficient with a maximum measured benefit achieving 100% of supplemented women.
Two in vitro mechanistic studies on human explants of adipose tissue have shown a significant increase of lipolysis by 94% in treated adipocytes of women with cellulite, as well as a significant reduction of adipocytes size, in the Cellulight group compared to control.
Bionov’s is to introduce Cellulights S, which it describes as a 100% natural active nutricosmetic ingredient for instant drink application and which the company says is the only ingredient with clinically demonstrated efficacy against cellulite.
It has a newly-developed coating to assure total dispersion in cold beverages. Stable in water and acid conditions, this grade S coating is also tasteless and colourless.
Cellulight S is a natural melon juice concentrate rich in superoxide dismutase (SOD), and was recognised as the Beauty Innovation of the year 2012 by the NuW Excellence Awards jury, at the Health Ingredients Europe Show in Frankfurt.
A double-blind, randomised placebo controlled clinical study on 41 healthy women with cellulite on thighs and/or stomach has demonstrated, according to the company, that Cellulight administered orally (40mg/day) reduces cellulite up to 9.5% (compared to placebo) after only 28 days of supplementation. This decrease reaches 11.3% after 56 days of supplementation. Results are said to have shown that the more cellulite is pronounced, the more Cellulight is efficient with a maximum measured benefit achieving 100% of supplemented women.
Two in vitro mechanistic studies on human explants of adipose tissue have shown a significant increase of lipolysis by 94% in treated adipocytes of women with cellulite, as well as a significant reduction of adipocytes size, in the Cellulight group compared to control.
Bionov’s is to introduce Cellulights S, which it describes as a 100% natural active nutricosmetic ingredient for instant drink application and which the company says is the only ingredient with clinically demonstrated efficacy against cellulite.
It has a newly-developed coating to assure total dispersion in cold beverages. Stable in water and acid conditions, this grade S coating is also tasteless and colourless.
Cellulight S is a natural melon juice concentrate rich in superoxide dismutase (SOD), and was recognised as the Beauty Innovation of the year 2012 by the NuW Excellence Awards jury, at the Health Ingredients Europe Show in Frankfurt.
A double-blind, randomised placebo controlled clinical study on 41 healthy women with cellulite on thighs and/or stomach has demonstrated, according to the company, that Cellulight administered orally (40mg/day) reduces cellulite up to 9.5% (compared to placebo) after only 28 days of supplementation. This decrease reaches 11.3% after 56 days of supplementation. Results are said to have shown that the more cellulite is pronounced, the more Cellulight is efficient with a maximum measured benefit achieving 100% of supplemented women.
Two in vitro mechanistic studies on human explants of adipose tissue have shown a significant increase of lipolysis by 94% in treated adipocytes of women with cellulite, as well as a significant reduction of adipocytes size, in the Cellulight group compared to control.
